Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
7.83
-0.29 (-3.57%)
At close: Sep 12, 2025, 4:00 PM EDT
7.98
+0.15 (1.92%)
After-hours: Sep 12, 2025, 5:05 PM EDT
Gyre Therapeutics Market Cap
Gyre Therapeutics has a market cap or net worth of $711.17 million as of September 12, 2025. Its market cap has decreased by -38.56% in one year.
Market Cap
711.17M
Enterprise Value
658.20M
1-Year Change
-38.56%
Ranking
Category
Stock Price
$7.83
Market Cap Chart
Since April 12, 2006, Gyre Therapeutics's market cap has increased from $165.40M to $711.17M, an increase of 329.97%. That is a compound annual growth rate of 7.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 754.10M | -33.36% |
| Dec 31, 2024 | 1.13B | 1,640.92% |
| Dec 29, 2023 | 65.00M | 291.57% |
| Dec 30, 2022 | 16.60M | -42.16% |
| Dec 31, 2021 | 28.70M | -79.41% |
| Dec 31, 2020 | 139.40M | 70.00% |
| Dec 31, 2019 | 82.00M | -12.95% |
| Dec 31, 2018 | 94.20M | 60.20% |
| Dec 29, 2017 | 58.80M | 653.85% |
| Dec 30, 2016 | 7.80M | -78.21% |
| Dec 31, 2015 | 35.80M | -60.31% |
| Dec 31, 2014 | 90.20M | -35.43% |
| Dec 31, 2013 | 139.70M | -5.10% |
| Dec 31, 2012 | 147.20M | -20.82% |
| Dec 30, 2011 | 185.90M | -75.52% |
| Dec 31, 2010 | 759.30M | 31.14% |
| Dec 31, 2009 | 579.00M | 551.29% |
| Dec 31, 2008 | 88.90M | -49.97% |
| Dec 31, 2007 | 177.70M | 2.72% |
| Dec 29, 2006 | 173.00M | 4.59% |
| Apr 12, 2006 | 165.40M | - |
View and export this data all the way back to 2006. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |